Idelalisib Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Idelalisib Tablet (tablet) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on 04/07/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Gilead Sciences, Inc.
- Package NDC
- 61958-1702-1
- Dosage Form
- Tablet
- Presentation
- Zydelig, Tablet, 150 mg (NDC 61958-1702-1)
- Initial Posting
- 04/07/2026
- Revised Date